首页 > 最新文献

Pharmacia最新文献

英文 中文
Influence of experimental heart failure therapy with different generations of β-adrenergic blockers on Cardiac Electrical Activity (ECG) and Autonomic Regulation of Heart Rhythm (ARHR) 不同代β-肾上腺素能阻滞剂治疗实验性心力衰竭对心电活动(ECG)和心律自主调节(ARHR)的影响Influence
Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-10-19 DOI: 10.3897/pharmacia.70.e110924
Olexiy Goncharov, Igor Belenichev, Andrii Abramov, Olena Popazova, Liudmyla Kucherenko, Nina Bukhtiyarova, Ivan Pavliuk
Abstract : In the complex treatment of chronic heart failure (CHF) β-adrenoblockers (carvedilol, nebivolol, bisoprolol, metoprolol) are used, which due to their pharmacological properties increase the survival rate of patients, improve cardio- and haemodynamic parameters, metabolism. However, modern realities in medicine require creation of new more effective and safe β-adrenoblockers. In this regard, the potential drug Hypertirl is of interest. The aim was to evaluate the cardioprotective effect of 1-(b-phenylethyl)-4-amino-1,2,4-triazolium bromide (Hypertril) on cardiac electrical activity and autonomic regulation of heart rhythm in a model of CHF in comparison with β-adrenoblockers of different generations (Nebivolol, Carvedilol, Bisoprolol, Metoprolol). Materials and methods : Chronic heart failure was induced by 14-day administration of doxorubicin in a cumulative dose of 15 mg/kg to white mongrel rats weighing 190–220g (total 85). The investigated drugs were administered after doxorubicin course for 30 days: Hypertril at an experimentally substantiated dose of 3.5 mg/kg, Metoprolol succinate 15 mg/kg, Nebivolol 10 mg/kg, Carvedilol 50 mg/kg, Bisoprolol 10 mg/kg. At the end of drug administration under thiopental anaesthesia (40 mg/kg), electrocardiogram (ECG) and autonomic regulation of heart rhythm (ARHR) were analysed using a computer analyser CardioCom-2000plus (KAI-Medica, Ukraine). The results of the study were calculated using a standard statistical package “STATISTICA for Windows 6.0” (StatSoftInc., №AXXR712D833214FAN5), “SPSS 16.0” and “Microsoft Office Excell 2003”. Results and discussion : Hypertril administration resulted in a negative chronotropic effect, normalisation of atrial (P) and ventricular (R) spike amplitude, ST segment inversion below isoline, increased amplitude of ventricular myocardial repolarisation T. Myocardial repolarisation spike were observed, as well as normalised the duration of atrial (P) and ventricular depolarisation phase (QRS complex) to the intact value and restored the duration of electrical diastole (TR interval). Hypertril reduced systolic and diastolic myocardial dysfunction in animals with CHF. Hypertril restored autonomic mechanisms of heart rhythm regulation and balanced activity of sympathetic and parasympathetic parts of autonomic nervous system in the control of cardiac function. Conclusion : The obtained results demonstrated the undoubted advantage of the new original molecule (Hypertril) over basic β-adrenoblockers (Metoprolol, Nebivolol, Carvedilol and Bisoprolol) and experimentally justify further in-depth study to create on its basis a drug for the treatment of CHF.
摘要:在慢性心力衰竭(CHF)的复杂治疗中,β-肾上腺素阻滞剂(卡维地洛、奈比洛尔、比索洛尔、美托洛尔)由于其药理特性可提高患者的生存率,改善心脏和血流动力学参数,改善代谢。然而,现代医学的现实需要创造新的更有效和安全的β-肾上腺素阻滞剂。在这方面,潜在的药物hypertil引起了人们的兴趣。目的是评估1-(b-苯乙基)-4-氨基-1,2,4-三唑溴化(Hypertril)对心电活动和心律自主调节的心脏保护作用,并与不同代β-肾上腺素阻滞剂(奈比洛尔、卡维地洛尔、比索洛尔、美托洛尔)进行比较。材料与方法:对体重190 ~ 220g的白杂种大鼠(共85只)给予15mg /kg累积剂量的阿霉素,14d诱导慢性心力衰竭。在阿霉素疗程后30天给药:实验确定剂量的海特利3.5 mg/kg,琥珀酸美托洛尔15 mg/kg,奈比洛尔10 mg/kg,卡维地洛50 mg/kg,比索洛尔10 mg/kg。在硫喷妥钠麻醉(40 mg/kg)给药结束时,使用计算机分析仪CardioCom-2000plus (KAI-Medica,乌克兰)分析心电图(ECG)和心律自主调节(ARHR)。使用标准统计软件包“STATISTICA for Windows 6.0”(StatSoftInc)计算研究结果。(编号:AXXR712D833214FAN5),“SPSS 16.0”和“Microsoft Office Excell 2003”。结果与讨论:高三吡嗪给药导致负变时效应,心房(P)和心室(R)尖峰幅值正常化,ST段倒置至等值线以下,心室心肌复极t幅值增加,心肌复极尖峰,心房(P)和心室去极化期(QRS复期)持续时间正常化至完整值,恢复电舒张期(TR间期)持续时间。高三嗪降低CHF动物的收缩和舒张心肌功能障碍。高三乐恢复心律调节的自主神经机制,平衡自主神经系统交感和副交感部分的活动,控制心功能。结论:所得结果证明了新分子(Hypertril)相对于碱性β-肾上腺素阻滞剂(美托洛尔、奈比洛尔、卡维地洛和比索洛尔)的优势是不容置疑的,并在实验上证明了进一步深入研究以其为基础研制治疗CHF的药物是合理的。
{"title":"Influence of experimental heart failure therapy with different generations of β-adrenergic blockers on Cardiac Electrical Activity (ECG) and Autonomic Regulation of Heart Rhythm (ARHR)","authors":"Olexiy Goncharov, Igor Belenichev, Andrii Abramov, Olena Popazova, Liudmyla Kucherenko, Nina Bukhtiyarova, Ivan Pavliuk","doi":"10.3897/pharmacia.70.e110924","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e110924","url":null,"abstract":"Abstract : In the complex treatment of chronic heart failure (CHF) β-adrenoblockers (carvedilol, nebivolol, bisoprolol, metoprolol) are used, which due to their pharmacological properties increase the survival rate of patients, improve cardio- and haemodynamic parameters, metabolism. However, modern realities in medicine require creation of new more effective and safe β-adrenoblockers. In this regard, the potential drug Hypertirl is of interest. The aim was to evaluate the cardioprotective effect of 1-(b-phenylethyl)-4-amino-1,2,4-triazolium bromide (Hypertril) on cardiac electrical activity and autonomic regulation of heart rhythm in a model of CHF in comparison with β-adrenoblockers of different generations (Nebivolol, Carvedilol, Bisoprolol, Metoprolol). Materials and methods : Chronic heart failure was induced by 14-day administration of doxorubicin in a cumulative dose of 15 mg/kg to white mongrel rats weighing 190–220g (total 85). The investigated drugs were administered after doxorubicin course for 30 days: Hypertril at an experimentally substantiated dose of 3.5 mg/kg, Metoprolol succinate 15 mg/kg, Nebivolol 10 mg/kg, Carvedilol 50 mg/kg, Bisoprolol 10 mg/kg. At the end of drug administration under thiopental anaesthesia (40 mg/kg), electrocardiogram (ECG) and autonomic regulation of heart rhythm (ARHR) were analysed using a computer analyser CardioCom-2000plus (KAI-Medica, Ukraine). The results of the study were calculated using a standard statistical package “STATISTICA for Windows 6.0” (StatSoftInc., №AXXR712D833214FAN5), “SPSS 16.0” and “Microsoft Office Excell 2003”. Results and discussion : Hypertril administration resulted in a negative chronotropic effect, normalisation of atrial (P) and ventricular (R) spike amplitude, ST segment inversion below isoline, increased amplitude of ventricular myocardial repolarisation T. Myocardial repolarisation spike were observed, as well as normalised the duration of atrial (P) and ventricular depolarisation phase (QRS complex) to the intact value and restored the duration of electrical diastole (TR interval). Hypertril reduced systolic and diastolic myocardial dysfunction in animals with CHF. Hypertril restored autonomic mechanisms of heart rhythm regulation and balanced activity of sympathetic and parasympathetic parts of autonomic nervous system in the control of cardiac function. Conclusion : The obtained results demonstrated the undoubted advantage of the new original molecule (Hypertril) over basic β-adrenoblockers (Metoprolol, Nebivolol, Carvedilol and Bisoprolol) and experimentally justify further in-depth study to create on its basis a drug for the treatment of CHF.","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":"124 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135779196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
 De novo design of pimarane diterpenoid compounds as potential alternatives to sarecycline for acne vulgaris treatment 重新设计海玛烷二萜化合物作为治疗寻常性痤疮的沙环素的潜在替代品
Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-10-19 DOI: 10.3897/pharmacia.70.e113065
Adeola Tawakalitu Kola-Mustapha
Acne vulgaris is a prevalent skin disorder that affects both adolescents and adults and has a major psychological impact. Antibiotic resistance is one issue that current therapies, including antibiotics, must address. A viable approach is to target Cutibacterium acnes , a crucial bacterium in the development of acne. An antibiotic of the tetracycline class called sarecycline shows efficacy despite resistance and adverse effect issues. The purpose of this study is to develop, assess, and compare the efficacy of Sandracopimar (Pimarane diterpenoids) compounds and Sarecycline in the treatment of acne by targeting the 30S ribosomal subunit of Cutibacterium acnes . Sarecycline’s binding affinity and PheSA score were assessed at the 30S ribosomal subunit binding site of Cutibacterium acnes . There were distinct interactions between Sarecycline and the ribosomal subunit, including hydrophobic and hydrogen bonding. Sarecycline demonstrated a strong binding affinity (-8.2 kcal/mol) and a PheSA score of 0.53184 within the Cutibacterium acnes 30S ribosomal subunit binding site. Sandaracopimar-15-ene-6.beta.,8.beta.-diol exhibited a binding affinity of -7.3 kcal/mol and PheSA score of 0.37252. Compound 1, a novel compound derived from Sandaracopimar-15-ene-6.beta.,8.beta.-diol, showed a slightly higher binding affinity (-8.3 kcal/mol) than Sarecycline. The molecular dynamics simulation results reveal that Compound 1 exhibited stability during a specific phase, indicating favorable binding potential with the Cutibacterium acnes 30S ribosomal subunit drug target. The compound demonstrated structural flexibility, advantageous for molecular interactions. The study indicates that Sandracopimar-derived compounds, including Compound 1, show comparable parameters to Sarecycline, suggesting similar activity in targeting the Cutibacterium acnes 30S ribosomal subunit. These compounds may serve as a potential source of novel anti-acne compounds.
寻常痤疮是一种流行的皮肤病,影响青少年和成年人,并有重大的心理影响。抗生素耐药性是目前包括抗生素在内的治疗方法必须解决的一个问题。一种可行的方法是针对痤疮角质杆菌,这是痤疮发展的关键细菌。四环素类的一种抗生素被称为沙环素,尽管存在耐药性和副作用问题,但仍显示出疗效。本研究旨在通过对痤疮表皮杆菌30S核糖体亚基的靶向治疗,开发、评估和比较海马兰二萜类化合物Sandracopimar和沙环素治疗痤疮的疗效。在痤疮表皮杆菌的30S核糖体亚基结合位点评估沙环素的结合亲和力和PheSA评分。沙环素与核糖体亚基之间存在明显的相互作用,包括疏水性和氢键。Sarecycline在痤疮表皮杆菌30S核糖体亚基结合位点表现出较强的结合亲和力(-8.2 kcal/mol), PheSA评分为0.53184。sandaracopimar, 15 -烯- 6. - beta 8. beta。-diol的结合亲和力为-7.3 kcal/mol, PheSA评分为0.37252。化合物1,一种新化合物,从山檀香-15-烯-6. β,8. β中提取。-二醇的结合亲和力(-8.3 kcal/mol)略高于沙环素。分子动力学模拟结果表明,化合物1在特定阶段表现出稳定性,表明与痤疮表皮杆菌30S核糖体亚基药物靶点具有良好的结合潜力。该化合物具有结构柔韧性,有利于分子间的相互作用。该研究表明,sandracopimar衍生的化合物,包括化合物1,与Sarecycline具有相似的参数,表明其靶向痤疮表皮杆菌30S核糖体亚基的活性相似。这些化合物可作为新型抗痤疮化合物的潜在来源。
{"title":" De novo design of pimarane diterpenoid compounds as potential alternatives to sarecycline for acne vulgaris treatment","authors":"Adeola Tawakalitu Kola-Mustapha","doi":"10.3897/pharmacia.70.e113065","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e113065","url":null,"abstract":"Acne vulgaris is a prevalent skin disorder that affects both adolescents and adults and has a major psychological impact. Antibiotic resistance is one issue that current therapies, including antibiotics, must address. A viable approach is to target Cutibacterium acnes , a crucial bacterium in the development of acne. An antibiotic of the tetracycline class called sarecycline shows efficacy despite resistance and adverse effect issues. The purpose of this study is to develop, assess, and compare the efficacy of Sandracopimar (Pimarane diterpenoids) compounds and Sarecycline in the treatment of acne by targeting the 30S ribosomal subunit of Cutibacterium acnes . Sarecycline’s binding affinity and PheSA score were assessed at the 30S ribosomal subunit binding site of Cutibacterium acnes . There were distinct interactions between Sarecycline and the ribosomal subunit, including hydrophobic and hydrogen bonding. Sarecycline demonstrated a strong binding affinity (-8.2 kcal/mol) and a PheSA score of 0.53184 within the Cutibacterium acnes 30S ribosomal subunit binding site. Sandaracopimar-15-ene-6.beta.,8.beta.-diol exhibited a binding affinity of -7.3 kcal/mol and PheSA score of 0.37252. Compound 1, a novel compound derived from Sandaracopimar-15-ene-6.beta.,8.beta.-diol, showed a slightly higher binding affinity (-8.3 kcal/mol) than Sarecycline. The molecular dynamics simulation results reveal that Compound 1 exhibited stability during a specific phase, indicating favorable binding potential with the Cutibacterium acnes 30S ribosomal subunit drug target. The compound demonstrated structural flexibility, advantageous for molecular interactions. The study indicates that Sandracopimar-derived compounds, including Compound 1, show comparable parameters to Sarecycline, suggesting similar activity in targeting the Cutibacterium acnes 30S ribosomal subunit. These compounds may serve as a potential source of novel anti-acne compounds.","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135778850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Co-occurrence of lung adenocarcinoma and pulmonary fibrosis in a patient: A comprehensive case study and review of existing literature on the successful utilization of nintedanib Co-occurrence对患者肺腺癌和肺纤维化的影响:对尼达尼布成功应用的综合案例研究和现有文献的回顾
Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-10-13 DOI: 10.3897/pharmacia.70.e111820
Tanya Zlatanova, Jeliazko Arabadjiev
Both lung carcinoma and idiopathic pulmonary fibrosis (IPF) have an adverse prognosis, and the co-existence of both diseases is not uncommon. We introduce a clinical case involving a patient diagnosed with concurrent occurrences of lung adenocarcinoma and IPF. The patient underwent a therapeutic regimen comprising the administration of docetaxel in conjunction with nintedanib. This treatment approach was followed by the sustained utilization of maintenance nintedanib over an extended duration, leading to substantial enhancements in the patient’s quality of life. Furthermore, we discuss the few therapeutic options concerning this clinical challenge and possible future therapeutic options.
肺癌和特发性肺纤维化(IPF)都有不良的预后,两种疾病共存并不罕见。我们介绍一个临床病例,涉及一位被诊断为同时发生肺腺癌和IPF的患者。患者接受了包括多西紫杉醇联合尼达尼布的治疗方案。在这种治疗方法之后,在较长时间内持续使用维持性尼达尼布,从而大大提高了患者的生活质量。此外,我们讨论了一些治疗方案有关的临床挑战和可能的未来治疗方案。
{"title":"Co-occurrence of lung adenocarcinoma and pulmonary fibrosis in a patient: A comprehensive case study and review of existing literature on the successful utilization of nintedanib","authors":"Tanya Zlatanova, Jeliazko Arabadjiev","doi":"10.3897/pharmacia.70.e111820","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e111820","url":null,"abstract":"Both lung carcinoma and idiopathic pulmonary fibrosis (IPF) have an adverse prognosis, and the co-existence of both diseases is not uncommon. We introduce a clinical case involving a patient diagnosed with concurrent occurrences of lung adenocarcinoma and IPF. The patient underwent a therapeutic regimen comprising the administration of docetaxel in conjunction with nintedanib. This treatment approach was followed by the sustained utilization of maintenance nintedanib over an extended duration, leading to substantial enhancements in the patient’s quality of life. Furthermore, we discuss the few therapeutic options concerning this clinical challenge and possible future therapeutic options.","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":"38 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135918836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A current insight and future perspective of edible bird nest as caviar of the east A食用燕窝作为东方鱼子酱的现状与未来展望
Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-10-13 DOI: 10.3897/pharmacia.70.e112494
Muhammad Andika Haraharap, Osfar Sjofjan, Lilik Eka Radiati, Muhammad Halim Natsir, Rony Abdi Syahputra, Fahrul Nurkolis
Edible bird’s nest (EBN) is a highly valuable food product obtained from swiftlet nests, primarily those of the Aerodramus genus. Due to its purported health benefits and exceptional taste, EBN is often referred to as the “caviar of the East.” This abstract presents a comprehensive review of the current state of EBN research, focusing on its chemical composition, nutritional value, pharmacological effects, and safety considerations. The chemical composition of EBN is intricate and influenced by various factors, including bird species, geographic origin, nest collection time, and processing methods. It is primarily composed of proteins, polysaccharides, minerals, lipids, and a wide range of bioactive compounds such as sialic acid, amino acids, and antioxidants. Additionally, EBN has demonstrated antioxidant, anti-inflammatory, anti-tumor, and anti-aging properties attributed to these bioactive constituents. While EBN is generally considered safe for human consumption, it is essential to address concerns related to potential contaminants like heavy metals, microbial pathogens, and allergens. This review offers a comprehensive overview of previous research conducted on residual impurities that may be present in edible bird’s nests (EBNs). The review encompasses various aspects, including, the regulatory framework and associated concerns regarding EBNs, the levels of nitrite and nitrate detected in EBNs, the presence of bacteria, fungi, and mites in EBNs, the identification of allergenic substances in EBNs, and the presence of heavy metals and excessive mineral content at different stages of EBN processing, including raw uncleaned (RUC) EBNs, raw cleaned (RC) EBNs, and EBNs after undergoing treatment. Graphical abstract :
食用燕窝(EBN)是一种从燕窝中获得的高价值食品,主要是飞蝇属的燕窝。由于其声称的健康益处和独特的味道,EBN通常被称为“东方鱼子酱”。这摘要提出了一个全面的审查现状的EBN研究,重点是其化学成分,营养价值,药理作用和安全考虑。鸟粪的化学成分复杂,受鸟类种类、产地、采巢时间和处理方法等因素的影响。它主要由蛋白质、多糖、矿物质、脂质和多种生物活性化合物(如唾液酸、氨基酸和抗氧化剂)组成。此外,EBN具有抗氧化、抗炎、抗肿瘤和抗衰老的特性,这些特性归功于这些生物活性成分。虽然EBN通常被认为对人类食用是安全的,但必须解决与重金属、微生物病原体和过敏原等潜在污染物有关的问题。本文综述了对食用燕窝(EBNs)中可能存在的残留杂质进行的研究的全面概述。审查涵盖了各个方面,包括:EBN的监管框架和相关问题,EBN中检测到的亚硝酸盐和硝酸盐水平,EBN中细菌、真菌和螨虫的存在,EBN中致敏物质的鉴定,以及EBN加工不同阶段(包括未经清洗的(RUC) EBN,未经清洗的(RC) EBN和经过处理的EBN)中重金属和过量矿物质含量的存在。图形摘要:
{"title":"A current insight and future perspective of edible bird nest as caviar of the east","authors":"Muhammad Andika Haraharap, Osfar Sjofjan, Lilik Eka Radiati, Muhammad Halim Natsir, Rony Abdi Syahputra, Fahrul Nurkolis","doi":"10.3897/pharmacia.70.e112494","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e112494","url":null,"abstract":"Edible bird’s nest (EBN) is a highly valuable food product obtained from swiftlet nests, primarily those of the Aerodramus genus. Due to its purported health benefits and exceptional taste, EBN is often referred to as the “caviar of the East.” This abstract presents a comprehensive review of the current state of EBN research, focusing on its chemical composition, nutritional value, pharmacological effects, and safety considerations. The chemical composition of EBN is intricate and influenced by various factors, including bird species, geographic origin, nest collection time, and processing methods. It is primarily composed of proteins, polysaccharides, minerals, lipids, and a wide range of bioactive compounds such as sialic acid, amino acids, and antioxidants. Additionally, EBN has demonstrated antioxidant, anti-inflammatory, anti-tumor, and anti-aging properties attributed to these bioactive constituents. While EBN is generally considered safe for human consumption, it is essential to address concerns related to potential contaminants like heavy metals, microbial pathogens, and allergens. This review offers a comprehensive overview of previous research conducted on residual impurities that may be present in edible bird’s nests (EBNs). The review encompasses various aspects, including, the regulatory framework and associated concerns regarding EBNs, the levels of nitrite and nitrate detected in EBNs, the presence of bacteria, fungi, and mites in EBNs, the identification of allergenic substances in EBNs, and the presence of heavy metals and excessive mineral content at different stages of EBN processing, including raw uncleaned (RUC) EBNs, raw cleaned (RC) EBNs, and EBNs after undergoing treatment. Graphical abstract :","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135918529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis and antitumor activity of 1,3,4-oxadiazole substituted 2-(5-ylidene-2,4-dioxothiazolidin-3-yl)-acetamides 1,3,4-恶二唑取代2-(5-酰基-2,4-二氧噻唑烷-3-基)-乙酰胺的合成及抗肿瘤活性
Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-10-12 DOI: 10.3897/pharmacia.70.e102449
Maryan Lelyukh, Myroslava Kalytovska, Marta Zastryzhna, Arkadii Savchenko, Ihor Chaban, Stefan Harkov
A series of novel 1,3,4-oxadiazole substituted 2-(5-aryl/heterylidene-2,4-dioxothiazolidine-3-ylidene)-acetamides and their 5-unsubstituted analogues have been synthesized following N -alkylation reaction of 2-chloro- N -(5-aryl-[1,3,4]oxadiazol-2-yl)-acetamides with thiazolidinedione and potassium salts of its arylidene derivatives. The structures of target compounds were confirmed by using 1H NMR spectroscopy and elemental analysis. Evaluation of anticancer activity in vitro for the synthesized compounds was performed in accordance with the National Cancer Institute protocol. A selective influence of some tested compounds against leukaemia MOLT-4 ( 3e , GP = 76.85%) and K-562 ( 3e , GP = 79.84%), colon cancer HCT-15 ( 3d , GP = 76.86%), renal cancer A498 ( 4a , GP = 74.37%), CAKI-1 ( 3d , GP = 68.49%) and UO-31 ( 3b-e, 4a-b , GP = 66.67 ÷ 86.30%) cell lines was established. Grafical abstract :
以2-氯- N -(5-芳基-[1,3,4]恶二唑-2-基)-乙酰酰胺为原料,与噻唑烷二酮及其芳基衍生物的钾盐进行N -烷基化反应,合成了一系列新的1,3,4-恶二唑取代的2-(5-芳基/杂基-2,4-二氧噻唑-3-芳基)-乙酰酰胺及其5-未取代的类似物。目的化合物的结构经核磁共振氢谱和元素分析证实。合成化合物的体外抗癌活性评估按照美国国家癌症研究所的方案进行。部分化合物对白血病MOLT-4 (3e, GP = 76.85%)和K-562 (3e, GP = 79.84%)、结肠癌HCT-15 (3d, GP = 76.86%)、肾癌A498 (4a, GP = 74.37%)、CAKI-1 (3d, GP = 68.49%)和UO-31 (3b-e, 4a-b, GP = 66.67 ÷ 86.30%)细胞株有选择性影响。图形摘要:
{"title":"Synthesis and antitumor activity of 1,3,4-oxadiazole substituted 2-(5-ylidene-2,4-dioxothiazolidin-3-yl)-acetamides","authors":"Maryan Lelyukh, Myroslava Kalytovska, Marta Zastryzhna, Arkadii Savchenko, Ihor Chaban, Stefan Harkov","doi":"10.3897/pharmacia.70.e102449","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e102449","url":null,"abstract":"A series of novel 1,3,4-oxadiazole substituted 2-(5-aryl/heterylidene-2,4-dioxothiazolidine-3-ylidene)-acetamides and their 5-unsubstituted analogues have been synthesized following N -alkylation reaction of 2-chloro- N -(5-aryl-[1,3,4]oxadiazol-2-yl)-acetamides with thiazolidinedione and potassium salts of its arylidene derivatives. The structures of target compounds were confirmed by using 1H NMR spectroscopy and elemental analysis. Evaluation of anticancer activity in vitro for the synthesized compounds was performed in accordance with the National Cancer Institute protocol. A selective influence of some tested compounds against leukaemia MOLT-4 ( 3e , GP = 76.85%) and K-562 ( 3e , GP = 79.84%), colon cancer HCT-15 ( 3d , GP = 76.86%), renal cancer A498 ( 4a , GP = 74.37%), CAKI-1 ( 3d , GP = 68.49%) and UO-31 ( 3b-e, 4a-b , GP = 66.67 ÷ 86.30%) cell lines was established. Grafical abstract :","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135963287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic toxicity assessment of nano-formulated Bischofia javanica leaves: Implications for pharmacological use Chronic纳米配方水芹叶的毒性评估:药理学用途的意义
Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-10-12 DOI: 10.3897/pharmacia.70.e110640
Cheryl Grace Pratiwi Rumahorbo, Syafruddin Ilyas, Salomo Hutahaean, Cut Fatimah Zuhra, Putri Cahaya Situmorang
This study explores the chronic toxicity of nano-formulated Bischofia javanica leaves, a plant with pharmacological significance in Indonesia, following OECD guidelines 452. Graded doses (2, 4, 6, and 8 g/kg BW) of nano-formulated Bischofia javanica were administered to the treatment groups for 60 days, while the control group (K-) received only water. On the 61 st day, the mice were euthanized, and samples for biochemical, hematological, and histopathological analysis were collected. Statistical analysis involved one-way ANOVA and Tukey’s post hoc tests. Graded doses of nano-formulated Bischofia javanica leaves caused significant alterations in liver function. Doses between 2 and 4 g/kg BW improved liver histology and physiological markers. Higher doses (6 to 8 g/kg BW) led to liver dysfunction and histological degeneration, characterized by substantial fatty alterations, intracellular fat accumulation in hepatocytes, and compromised central blood vessels and sinusoids. The lungs showed signs of alveolar inflammation, epithelial exfoliation, debris, and the accumulation of inflammatory cells in alveolar spaces. Lower doses showed uniformly distributed cardiac blood vessels, while higher doses resulted in heart hemorrhages and amorphous exudates. Except for high doses, which significantly elevated specific liver damage indicators, no other levels of Bischofia javanica caused treatment-related mortality or significant alterations in hematological and biochemical parameters. Blood sugar levels remained stable across the dose range. In conclusion, moderate doses of nano-formulated Bischofia javanica leaf extracts can enhance physiological functions positively. However, caution is necessary when contemplating high doses, as they can cause dysfunction or damage vital organ systems.
本研究探讨了纳米配方爪哇Bischofia javica叶的慢性毒性,该植物在印度尼西亚具有药理意义,遵循OECD指南452。给药组分别给予2、4、6、8 g/kg BW纳米配方爪哇Bischofia,连续60天,对照组(K-)只给予水。第61天对小鼠实施安乐死,收集生化、血液学和组织病理学样本。统计分析采用单因素方差分析和Tukey事后检验。分级剂量的纳米配方水芹叶引起肝功能的显著改变。2 - 4 g/kg体重的剂量可改善肝脏组织学和生理指标。较高剂量(6 - 8 g/kg体重)导致肝功能障碍和组织学变性,其特征是大量脂肪改变,肝细胞内脂肪堆积,中枢血管和窦状动脉受损。肺部表现为肺泡炎症、上皮脱落、碎片和肺泡间隙炎症细胞积聚的迹象。低剂量显示血管均匀分布,而高剂量导致心脏出血和无定形渗出物。除了高剂量会显著提高特定肝损伤指标外,其他水平的爪牙比肖亚没有引起治疗相关的死亡率或血液学和生化参数的显著改变。在整个剂量范围内,血糖水平保持稳定。综上所述,中等剂量的爪哇花叶纳米提取物对小鼠的生理功能有积极的促进作用。然而,在考虑高剂量时必须谨慎,因为它们会导致功能障碍或损害重要器官系统。
{"title":"Chronic toxicity assessment of nano-formulated Bischofia javanica leaves: Implications for pharmacological use","authors":"Cheryl Grace Pratiwi Rumahorbo, Syafruddin Ilyas, Salomo Hutahaean, Cut Fatimah Zuhra, Putri Cahaya Situmorang","doi":"10.3897/pharmacia.70.e110640","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e110640","url":null,"abstract":"This study explores the chronic toxicity of nano-formulated Bischofia javanica leaves, a plant with pharmacological significance in Indonesia, following OECD guidelines 452. Graded doses (2, 4, 6, and 8 g/kg BW) of nano-formulated Bischofia javanica were administered to the treatment groups for 60 days, while the control group (K-) received only water. On the 61 st day, the mice were euthanized, and samples for biochemical, hematological, and histopathological analysis were collected. Statistical analysis involved one-way ANOVA and Tukey’s post hoc tests. Graded doses of nano-formulated Bischofia javanica leaves caused significant alterations in liver function. Doses between 2 and 4 g/kg BW improved liver histology and physiological markers. Higher doses (6 to 8 g/kg BW) led to liver dysfunction and histological degeneration, characterized by substantial fatty alterations, intracellular fat accumulation in hepatocytes, and compromised central blood vessels and sinusoids. The lungs showed signs of alveolar inflammation, epithelial exfoliation, debris, and the accumulation of inflammatory cells in alveolar spaces. Lower doses showed uniformly distributed cardiac blood vessels, while higher doses resulted in heart hemorrhages and amorphous exudates. Except for high doses, which significantly elevated specific liver damage indicators, no other levels of Bischofia javanica caused treatment-related mortality or significant alterations in hematological and biochemical parameters. Blood sugar levels remained stable across the dose range. In conclusion, moderate doses of nano-formulated Bischofia javanica leaf extracts can enhance physiological functions positively. However, caution is necessary when contemplating high doses, as they can cause dysfunction or damage vital organ systems.","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135969951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monitoring the change in the quality of life of patients with post-COVID syndrome by influence on their functional status Monitoring新冠肺炎后患者生活质量的变化对其功能状态的影响
Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-10-12 DOI: 10.3897/pharmacia.70.e113061
Maria Stamova Vakrilova Becheva, Angelina Georgieva Kirkova-Bogdanova, Petar Jordanov Atanasov, Mariya Sevdelinova Chaneva, Daniela Ivova Taneva, Stefka Achkova Ivanova
Coronavirus disease 2019 (COVID-19) is still a major medical concern. Patients who have recovered from the infection from COVID-19 face the ordeal of post-covid syndrome. In these patients, there is a decrease in physical abilities, in particular musculoskeletal complications and post-traumatic stress, depression and chronic fatigue, which impair their quality of life. This necessitates long-term rehabilitation, which supports recovery after hospitalization. Treatment through movement is part of the rehabilitation measures contributing to the functional recovery of patients with post-covid syndrome. To study how the functional capabilities of these patients improve and how their quality of life is affected, we created a set of physical exercises to be performed at home for 6 months. At baseline and at the end of the study, patients completed the SF-36 quality of life questionnaire. The aim of the study was to track the changes in the quality of life of patients with post-covid syndrome by influencing their functional state. Our study found a decline in the quality of life of the examined patients. After the application of the kinesitherapy program, the functional status of the patients improved, their functional independence was optimized, which contributed to the improvement of the quality of life of the post-covid patients syndrome.
2019冠状病毒病(COVID-19)仍然是一个主要的医学问题。从新冠肺炎感染中恢复过来的患者面临着“后冠综合征”的折磨。在这些患者中,身体能力下降,特别是肌肉骨骼并发症和创伤后应激、抑郁和慢性疲劳,损害了他们的生活质量。这就需要长期康复,以支持住院后的康复。通过运动进行治疗是有助于covid - 19综合征患者功能恢复的康复措施的一部分。为了研究这些患者的功能能力是如何改善的,以及他们的生活质量是如何受到影响的,我们设计了一套为期6个月的在家进行的体育锻炼。在基线和研究结束时,患者完成SF-36生活质量问卷。该研究的目的是通过影响患者的功能状态来跟踪新冠肺炎后综合征患者生活质量的变化。我们的研究发现,接受检查的病人的生活质量有所下降。应用运动疗法方案后,患者的功能状态得到改善,功能独立性得到优化,有助于改善新冠后综合征患者的生活质量。
{"title":"Monitoring the change in the quality of life of patients with post-COVID syndrome by influence on their functional status","authors":"Maria Stamova Vakrilova Becheva, Angelina Georgieva Kirkova-Bogdanova, Petar Jordanov Atanasov, Mariya Sevdelinova Chaneva, Daniela Ivova Taneva, Stefka Achkova Ivanova","doi":"10.3897/pharmacia.70.e113061","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e113061","url":null,"abstract":"Coronavirus disease 2019 (COVID-19) is still a major medical concern. Patients who have recovered from the infection from COVID-19 face the ordeal of post-covid syndrome. In these patients, there is a decrease in physical abilities, in particular musculoskeletal complications and post-traumatic stress, depression and chronic fatigue, which impair their quality of life. This necessitates long-term rehabilitation, which supports recovery after hospitalization. Treatment through movement is part of the rehabilitation measures contributing to the functional recovery of patients with post-covid syndrome. To study how the functional capabilities of these patients improve and how their quality of life is affected, we created a set of physical exercises to be performed at home for 6 months. At baseline and at the end of the study, patients completed the SF-36 quality of life questionnaire. The aim of the study was to track the changes in the quality of life of patients with post-covid syndrome by influencing their functional state. Our study found a decline in the quality of life of the examined patients. After the application of the kinesitherapy program, the functional status of the patients improved, their functional independence was optimized, which contributed to the improvement of the quality of life of the post-covid patients syndrome.","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136013188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Weight management strategies and food supplement intake among Bulgarian adults: results of a national survey Weight保加利亚成年人的管理策略和食品补充剂摄入:一项全国调查的结果
Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-10-12 DOI: 10.3897/pharmacia.70.e109835
Radiana Staynova, Vesselina Yanachkova
The number of overweight and obese people has dramatically risen in the last two decades and has become one of the most serious health concerns. This study aimed to assess the use of food supplements as aids in reducing body weight and different approaches for weight management practised by Bulgarian adults. A cross-sectional, questionnaire-based online survey was conducted between December 2019 and February 2020. A total of 508 adults completed the survey. According to study participants, the Internet was the most used source of weight reduction information (66.9%). One hundred and seventy-two adults (33.9%) have sought weight-loss advice from a personal trainer/fitness instructor, and only 12.6% (n = 64) have consulted with a physician. More than half of the respondents (n = 288, 56.7%) reported food supplement use to maintain weight. The majority of the consumers were female (76.4%, p < 0.001) and adults with higher education (89.9%, p < 0.001). The main reasons for food supplement intake were individual research on the Internet (43%), advice from a personal trainer/fitness instructor (23.6%), and a recommendation from a healthcare provider (22.2%). With the increasing rates of overweight and obesity, food supplements are becoming a popular weight-loss approach, which is confirmed by our findings.
在过去的二十年里,超重和肥胖人群的数量急剧增加,并已成为最严重的健康问题之一。本研究旨在评估保加利亚成年人使用食品补充剂作为减轻体重的辅助手段和体重管理的不同方法。在2019年12月至2020年2月期间进行了一项基于问卷的横断面在线调查。共有508名成年人完成了这项调查。根据研究参与者,互联网是最常用的减肥信息来源(66.9%)。172名成年人(33.9%)曾向私人教练/健身教练寻求减肥建议,只有12.6% (n = 64)曾咨询过医生。超过一半的受访者(n = 288, 56.7%)表示使用食物补充剂来保持体重。消费者以女性为主(76.4%,p <0.001)和受过高等教育的成年人(89.9%,p <0.001)。摄入食物补充剂的主要原因是网上的个人研究(43%)、私人教练/健身教练的建议(23.6%)和医疗保健提供者的建议(22.2%)。随着超重和肥胖率的上升,食品补充剂正成为一种流行的减肥方法,我们的研究结果证实了这一点。
{"title":"Weight management strategies and food supplement intake among Bulgarian adults: results of a national survey","authors":"Radiana Staynova, Vesselina Yanachkova","doi":"10.3897/pharmacia.70.e109835","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e109835","url":null,"abstract":"The number of overweight and obese people has dramatically risen in the last two decades and has become one of the most serious health concerns. This study aimed to assess the use of food supplements as aids in reducing body weight and different approaches for weight management practised by Bulgarian adults. A cross-sectional, questionnaire-based online survey was conducted between December 2019 and February 2020. A total of 508 adults completed the survey. According to study participants, the Internet was the most used source of weight reduction information (66.9%). One hundred and seventy-two adults (33.9%) have sought weight-loss advice from a personal trainer/fitness instructor, and only 12.6% (n = 64) have consulted with a physician. More than half of the respondents (n = 288, 56.7%) reported food supplement use to maintain weight. The majority of the consumers were female (76.4%, p &amp;lt; 0.001) and adults with higher education (89.9%, p &amp;lt; 0.001). The main reasons for food supplement intake were individual research on the Internet (43%), advice from a personal trainer/fitness instructor (23.6%), and a recommendation from a healthcare provider (22.2%). With the increasing rates of overweight and obesity, food supplements are becoming a popular weight-loss approach, which is confirmed by our findings.","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136013355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The most promising Southeastern European Tanacetum species: a review of chemical composition and biological studies 最有前途的东南欧Tanacetum物种:化学成分和生物学研究综述
Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-10-11 DOI: 10.3897/pharmacia.70.e110748
Reneta Gevrenova, Vessela Balabanova, Dimitrina Zheleva-Dimitrova, Georgi Momekov
Several species of the genus Tanacetum L. (Asteraceae) spread in the Southestern Europe are traditionally used as medicinal and aromatic plants, including T. vulgare , T. parthenium , T. macrophyllum , T. balsamita , T. poteriifolium . The review is focused on the phytochemical and pharmacological studies of these taxa. Major chemical constituents are acylquinic acids, sesquiterpenes, sesquiterpene lactones, methoxylated flavonoids. An in-depth depiction of more than 100 secondary metabolites was achieved in Tanacetum species by liquid chromatography-high resolution mass spectrometry. The ethnopharmacological studies indicate that species possess antioxidant, enzyme inhibitory and cytotoxic activity along with antimicrobial and antiviral effects. Reports revealed anti-inflamatory and neuromodulatory activity involved in the pharmacological approach in counteracting migraine attacks. Multivariate data analysis allowed the identification of the most discriminant metabolites and bioactivities in the herbal drugs. This review emphasizes T. vulgare , T. macrophyllum , T. balsamita and T. parthenium as potential raw material for health-promoting application in pharmaceutical area.
分布在欧洲东南部的几个品种是传统上用作药用和芳香植物,包括T. vulgare, T. parthenium, T. macrophyllum, T. balsamita, T. poterifolium。本文就其植物化学和药理研究进展作一综述。主要化学成分为酰基奎宁酸、倍半萜、倍半萜内酯、甲氧基黄酮类化合物。采用液相色谱-高分辨率质谱联用技术对Tanacetum中100多种次生代谢物进行了深入分析。民族药理学研究表明,该植物具有抗氧化、酶抑制和细胞毒活性,并具有抗菌和抗病毒作用。报告显示抗炎和神经调节活动参与对抗偏头痛发作的药理学方法。通过多变量数据分析,确定了中草药中最具鉴别性的代谢物和生物活性。本文着重介绍了普通赤霉素、大叶赤霉素、香茅赤霉素和帕特拉姆赤霉素在医药保健领域的潜在应用前景。
{"title":"The most promising Southeastern European Tanacetum species: a review of chemical composition and biological studies","authors":"Reneta Gevrenova, Vessela Balabanova, Dimitrina Zheleva-Dimitrova, Georgi Momekov","doi":"10.3897/pharmacia.70.e110748","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e110748","url":null,"abstract":"Several species of the genus Tanacetum L. (Asteraceae) spread in the Southestern Europe are traditionally used as medicinal and aromatic plants, including T. vulgare , T. parthenium , T. macrophyllum , T. balsamita , T. poteriifolium . The review is focused on the phytochemical and pharmacological studies of these taxa. Major chemical constituents are acylquinic acids, sesquiterpenes, sesquiterpene lactones, methoxylated flavonoids. An in-depth depiction of more than 100 secondary metabolites was achieved in Tanacetum species by liquid chromatography-high resolution mass spectrometry. The ethnopharmacological studies indicate that species possess antioxidant, enzyme inhibitory and cytotoxic activity along with antimicrobial and antiviral effects. Reports revealed anti-inflamatory and neuromodulatory activity involved in the pharmacological approach in counteracting migraine attacks. Multivariate data analysis allowed the identification of the most discriminant metabolites and bioactivities in the herbal drugs. This review emphasizes T. vulgare , T. macrophyllum , T. balsamita and T. parthenium as potential raw material for health-promoting application in pharmaceutical area.","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136098165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The era of digital pharmacy. 3D printing - realities and perspectives 数字药房时代。3D打印-现实和前景
Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-10-11 DOI: 10.3897/pharmacia.70.e111731
Milen Dimitrov, Dilyana Georgieva, Sofiya Ilieva, Valentina Petkova
3D printing is an innovative technology for building three-dimensional objects by laying down successive layers of material under the control of a computer software. It is entering pharmacy mainly because of its revolutionary potential to provide individualized dosage forms that meet the needs of each patient, due to the possibility to produce objects of many different sizes and shapes. An important aspect of personalized 3D tablets is the possibility to include several active substances in one dosage form, which would reduce the daily number of medications and the frequency of their administration and improve patient compliance. Another advantage of 3D printing is the possibility of producing small batches or even individual drugs for each patient. Despite the many advantages, 3D printing has several technological challenges to overcome before it becomes widely applicable in pharmacy. Five basic technologies are currently applied in pharmaceutical practice: powder-based printing, selective laser sintering, stereolithography, extrusion moulding printing, and electrohydrodynamic 3D printing. This article reviewed development, research focus, and prospects of each technology respectively.
3D打印是一项创新技术,通过在计算机软件的控制下铺设连续的材料层来构建三维物体。它之所以进入制药领域,主要是因为它具有革命性的潜力,可以提供满足每个病人需要的个性化剂型,因为它可以生产许多不同大小和形状的物品。个性化3D片剂的一个重要方面是可能在一种剂型中包含几种活性物质,这将减少每天的药物数量和给药频率,并提高患者的依从性。3D打印的另一个优点是可以为每个病人生产小批量甚至单个药物。尽管3D打印有很多优点,但在它广泛应用于制药之前,还需要克服一些技术挑战。目前在制药实践中应用的五种基本技术:粉末印刷、选择性激光烧结、立体光刻、挤压成型印刷和电流体动力3D打印。本文分别综述了各技术的发展现状、研究重点和前景。
{"title":"The era of digital pharmacy. 3D printing - realities and perspectives","authors":"Milen Dimitrov, Dilyana Georgieva, Sofiya Ilieva, Valentina Petkova","doi":"10.3897/pharmacia.70.e111731","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e111731","url":null,"abstract":"3D printing is an innovative technology for building three-dimensional objects by laying down successive layers of material under the control of a computer software. It is entering pharmacy mainly because of its revolutionary potential to provide individualized dosage forms that meet the needs of each patient, due to the possibility to produce objects of many different sizes and shapes. An important aspect of personalized 3D tablets is the possibility to include several active substances in one dosage form, which would reduce the daily number of medications and the frequency of their administration and improve patient compliance. Another advantage of 3D printing is the possibility of producing small batches or even individual drugs for each patient. Despite the many advantages, 3D printing has several technological challenges to overcome before it becomes widely applicable in pharmacy. Five basic technologies are currently applied in pharmaceutical practice: powder-based printing, selective laser sintering, stereolithography, extrusion moulding printing, and electrohydrodynamic 3D printing. This article reviewed development, research focus, and prospects of each technology respectively.","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136062447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pharmacia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1